Advertisement

Dysplasia in Inflammatory Bowel Disease: from Genetics to Treatment

  • Emil Salmo
  • Patrick O’Connolly
  • Najib Haboubi

Conclusions

  • Definition of dysplasia is standard.

  • Classifications are clear.

  • Genetic studies are variable and may be useful in differentiating between lesions and helpful in choosing treatment modalities.

  • Treatment varies according to condition of lesion.

  • Not all CRC in IBD follow the logic of the lowgrade dysplasia, high-grade dysplasia then carcinoma sequence.

  • Modified chromoendoscopy is more sensitive than routine endoscopy in identifying dysplastic epithelium.

Keywords

Inflammatory Bowel Disease Ulcerative Colitis Chronic Ulcerative Colitis Dysplastic Lesion Random Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ullman TA (2005) Preventing neoplastic progression in ulcerative colitis. J Clin Gastroenterol 39(4):S66–S69PubMedCrossRefGoogle Scholar
  2. 2.
    Sjoqvist U (2004) Dysplasia in ulcerative colitis: clinical consequences? Langenbecks Arch Surg 389(5):354–360PubMedCrossRefGoogle Scholar
  3. 3.
    Itzkowitz SH, Present DH (2005) Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11(3):314–321PubMedCrossRefGoogle Scholar
  4. 4.
    Judge TA, Lewis JD, Lichtenstein GR (2002) Colonic dysplasia and cancer in inflammatory bowel disease. Gastrointest Endosc Clin N Am 12(3):495–523PubMedCrossRefGoogle Scholar
  5. 5.
    Ekbom A, Helmick C, Zack M et al (1990) Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 323(18):1228–1233PubMedCrossRefGoogle Scholar
  6. 6.
    Sugita A, Sachar DB, Bodian C et al (1991) Colorectal cancer in ulcerative colitis: influence of anatomical extent and age at onset on colitis-cancer interval. Gut 32(2):167–169PubMedGoogle Scholar
  7. 7.
    Chambers WM, Warren BF, Jewell DP et al (2005) Cancer surveillance in ulcerative colitis. Br J Surg 92(8):928–936PubMedCrossRefGoogle Scholar
  8. 8.
    Riddell RH, Goldman H, Ransohoff DF et al (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14(11):931–968PubMedCrossRefGoogle Scholar
  9. 9.
    Konishi F, Wakasa H, Kino I et al (1993) Histological classification of the neoplastic epithelium arising in ulcerative colitis (in Japanese with English abstract). Annual Report (for 1992) of the Research Committee of Inflammatory Bowel Disease Tokyo, Ministry of Health and Welfare of Japan, Tokyo, pp 153–156Google Scholar
  10. 10.
    Schlemper RJ, Riddell RH, Kato Y et al (2000) The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47(2):251–155PubMedCrossRefGoogle Scholar
  11. 11.
    Schlemper RJ, Kato Y, Stolte M (2000) Diagnostic criteria for gastrointestinal carcinomas in Japan and western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol 15:49–57CrossRefGoogle Scholar
  12. 12.
    Schlemper RJ, Iwashita I (2004) Classification of gastrointestinal epithelial neoplasia. Current Diagnos Pathol 10(2):128–139CrossRefGoogle Scholar
  13. 13.
    Harpaz N (2004) Adenoma-like dysplastic polyps in inflammatory bowel disease. Pathol Case Rev9(4):135–141CrossRefGoogle Scholar
  14. 14.
    Odze RD (1999) Adenomas and adenoma-like DALMs in chronic ulcerative colitis: a clinical, pathological, and molecular review. Am J Gastroenterol 94(7):1746–1750PubMedCrossRefGoogle Scholar
  15. 15.
    Melville DM, Jass JR, Morson BC et al (1989) Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 20:1008–1014PubMedCrossRefGoogle Scholar
  16. 16.
    Dixon MF, Brown LJR, Gilmour HM et al (1988) Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 13:385–397PubMedGoogle Scholar
  17. 17.
    Hulten L, Willen R, Nilsson O et al (2002) Mucosal assessment for dysplasia and cancer in the ileal-pouch mucosa in patients operated on for ulcerative colitis: a 30-year follow-up study. Dis Colon Rectum 45(4):448–452PubMedCrossRefGoogle Scholar
  18. 18.
    Raithel M, Weidenhiller M, Schwab D et al (2001) Pathobiology of dysplasia in chronic inflammatory bowel disease: current recommendation for surveillance of dysplasia. Z Gastroenterol 39(10):861–875PubMedCrossRefGoogle Scholar
  19. 19.
    Yin J, Harpaz N, Tong Y et al (1993) p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 104(6):1633–1639PubMedGoogle Scholar
  20. 20.
    Bernstein CN, Shanahan F, Weinstein WM (1994) Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 8(343):71–74Google Scholar
  21. 21.
    Levine DS, Reid BJ, Haggitt RC et al (1991) Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology 101(5):1198–210PubMedGoogle Scholar
  22. 22.
    Rutegard J, Ahsgren L, Stenling R et al (1988) DNA content in ulcerative colitis: flow cytometric analysis in a patient series from a defined area. Dis Colon Rectum 31:710–715PubMedCrossRefGoogle Scholar
  23. 23.
    Schneider A, Stolte M (1993) Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis. Z Gastroenterol 31(11):653–656PubMedGoogle Scholar
  24. 24.
    Torres C, Antonioli D, Odze RD (1998) Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients. Am J Surg Pathol 22(3):275–284PubMedCrossRefGoogle Scholar
  25. 25.
    Fogt F, Wellmann A, Urbanski SJ et al (2001) Glut-1 expression in dysplastic and regenerative lesions of the colon. Int J Mol Med 7(6):615–619PubMedGoogle Scholar
  26. 26.
    Fogt F, Zimmerman RL, Poremba C et al (2002) Immunohistochemical screening of mismatch repair genes hMLH1, hMSH2, and hMSH6 in dysplastic lesions of the colon. Appl Immunohistochem Mol Morphol 10(1):57–61PubMedCrossRefGoogle Scholar
  27. 27.
    Mueller E, Vieth M, Stolte M et al (1999) The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. Hum Pathol 30(8):898–905PubMedCrossRefGoogle Scholar
  28. 28.
    Walsh SV, Loda M, Torres CM et al (1999) P53 and beta catenin expression in chronic ulcerative colitisassociated polypoid dysplasia and sporadic adenomas: an immunohistochemical study. Am J Surg Pathol 23(8):963–969PubMedCrossRefGoogle Scholar
  29. 29.
    Powell SM, Zilz N, Beazer-Barclay Y et al (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359(6392):235–237PubMedCrossRefGoogle Scholar
  30. 30.
    Tarmin L, Yin J, Harpaz N al (1995) Adenomatous polyposis coli gene mutations in ulcerative colitisassociated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 55(10):2035–2038PubMedGoogle Scholar
  31. 31.
    Andersen SN, Lovig T, Clausen OP et al (1999) Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations. Gut 45(5):686–692PubMedCrossRefGoogle Scholar
  32. 32.
    Chaubert P, Benhattar J, Saraga E et al (1994) K-ras mutations and p53 alterations in neoplastic and non neoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 144(4):767–775PubMedGoogle Scholar
  33. 33.
    Odze RD, Brown CA, Hartmann CJ et al (2000) Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs is similar to non-colitic sporadic adenomas. Am J Surg Pathol 24:1209–1216PubMedCrossRefGoogle Scholar
  34. 34.
    Fogt F, Urbanski SJ, Sanders ME et al (2000) Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis. Hum Pathol 31:288–291PubMedCrossRefGoogle Scholar
  35. 35.
    Fujii S, Fujimori T, Kashida H (2002) Ulcerative colitis-associated neoplasia. Pathol Int 52(3):195–203PubMedCrossRefGoogle Scholar
  36. 36.
    Willenbucher RF, Aust DE, Chang CG et al (1999) Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol 154(6):1825–1830PubMedGoogle Scholar
  37. 37.
    Brentnall TA, Crispin DA, Bronner MP et al 1996) Microsatellite instability in non neoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 56(6):1237–1240PubMedGoogle Scholar
  38. 38.
    Cawkwell L, Sutherland F, Murgatroyd H et al (2000) Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut 46(3):367–369PubMedCrossRefGoogle Scholar
  39. 39.
    Hsieh CJ, Klump B, Holzmann K et al (1998) Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 58(17):3942–3945PubMedGoogle Scholar
  40. 40.
    van der Woude CJ, Moshage H, Homan M et al (2005) Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis. J Clin Pathol 58(8):811–814PubMedCrossRefGoogle Scholar
  41. 41.
    Crohn B, Rosenberg H (1925) The sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci 170:220–228CrossRefGoogle Scholar
  42. 42.
    Warren S, Sommers SC (1949) Pathogenesis of ulcerative colitis Am J Pathol 25:657–679PubMedGoogle Scholar
  43. 43.
    Morson BC, Pang LS (1967) Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 8(5):423–434PubMedGoogle Scholar
  44. 44.
    Connell WR, Talbot IC, Harpaz N et al (1994) Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 35(10):1419–1423PubMedGoogle Scholar
  45. 45.
    Bernstein CN (2005) The case of colectomy in patients with low-grade dysplasia in ulcerative colitis. World Gastroenterol News 10(2):12–13Google Scholar
  46. 46.
    Manning AP, Bulgim OR, Dixon MF et al (1987) Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut 28(11):1489–1494PubMedGoogle Scholar
  47. 47.
    Nugent FW, Haggitt RC, Gilpin PA (1991) Cancer surveillance in ulcerative colitis. Gastroenterology 100(5):1241–1248PubMedGoogle Scholar
  48. 48.
    Eaden JA, Mayberry JF (2002) Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 1(Suppl 5):10–12CrossRefGoogle Scholar
  49. 49.
    Itzkowitz SH, Harpaz N (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126(6):1634–1648PubMedCrossRefGoogle Scholar
  50. 50.
    Rubin CE, Haggitt RC, Burmer GC et al (1992) DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 103(5):1611–1620PubMedGoogle Scholar
  51. 51.
    Rosenstock E, Farmer RG, Petras R et al (1985) Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 89(6):1342–1346PubMedGoogle Scholar
  52. 52.
    Ullman T, Croog V, Harpaz N et al (2003) Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125(5):1311–1319PubMedCrossRefGoogle Scholar
  53. 53.
    Gorfine SR, Bauer JJ, Harris MT et al (2000) Dysplasia complicating chronic ulcerative colitis: Is immediate colectomy warranted? Dis Colon Rectum 43(11):1575–1581PubMedCrossRefGoogle Scholar
  54. 54.
    Befrits R, Ljung T, Jaramillo E et al (2002) Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow-up study. Dis Colon Rectum 45(5):615–620PubMedCrossRefGoogle Scholar
  55. 55.
    Rutter MD, Saunders BP, Schofield G et al (2004) Pan colonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 53(2):256–260PubMedCrossRefGoogle Scholar
  56. 56.
    Bowles CJ, Leicester R, Romaya C et al (2004) A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut 53(2):277–283PubMedCrossRefGoogle Scholar
  57. 57.
    Mayer R, Wong WD, Rosenberger DA et al (1999) Colorectal cancer in inflammatory bowel disease: a continuing problem. Dis Colon Rectum 42(3):343–347PubMedCrossRefGoogle Scholar
  58. 58.
    Mpofu C, Watson AJ, Rhodes JM (2004) Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2:CD000279Google Scholar
  59. 59.
    Herfarth H, Rogler G (2005) Inflammatory bowel disease. Endoscopy 37(1):42–47PubMedCrossRefGoogle Scholar
  60. 60.
    Kiesslich R, Neurath MF (2004) Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight. Gut 53:165–167PubMedCrossRefGoogle Scholar
  61. 61.
    Becker C, Fantini MC, Wirtz S et al (2005) In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 54(7):950–954PubMedCrossRefGoogle Scholar
  62. 62.
    Kiesslich R, Fritsch J, Holtmann M et al (2003) Methylene blue aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124(4):880–888PubMedCrossRefGoogle Scholar
  63. 63.
    Rutter MD, Saunders BP, Wilkinson KH et al (2004) Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 60(3):334–339PubMedCrossRefGoogle Scholar
  64. 64.
    Trecca A, Gai F, Di Lorenzo GP et al (2004) Conventional colonoscopy versus chromoendoscopy and magnifying endoscopy for the diagnosis of colorectal lesions: a comparative prospective study in 995 patients. Chir Ital 56(1):31–36PubMedGoogle Scholar
  65. 65.
    Kiesslich R, Neurath MF (2004) Potential of new endoscopic techniques: intravital staining and in vivo confocal endomicroscopy in the detection of premalignant lesions and early cancer in patients with ulcerative colitis. Acta Endoscop 34(2): 189–197CrossRefGoogle Scholar
  66. 66.
    Hurlstone DP (2004) Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 126(1):376–378PubMedCrossRefGoogle Scholar
  67. 67.
    Inoue H, Kudo SE, Shiokawa A (2004) Novel endoscopic imaging techniques toward in vivo observation of living cancer cells in the gastrointestinal tract. Dig Dis 22(4):334–337PubMedCrossRefGoogle Scholar
  68. 68.
    Dekker E, Fockens P (2005) Advances in colonic imaging: new endoscopic imaging methods. Eur J Gastroenterol Hepatol 17(8):803–808PubMedCrossRefGoogle Scholar
  69. 69.
    Ullman TA (2005) Colonoscopic surveillance in inflammatory bowel disease. Curr Opin Gastroenterol 21(5):585–588PubMedCrossRefGoogle Scholar
  70. 70.
    Rutter M, Saunders B, Wilkinson K et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126(2):451–359PubMedCrossRefGoogle Scholar
  71. 71.
    Blackstone MO, Riddell RH, Rogers BH et al (1981) Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 80(2):366–374PubMedGoogle Scholar
  72. 72.
    Engelsgjerd M, Farraye FA, Odze RD (1999) Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 117(6):1288–1294PubMedCrossRefGoogle Scholar
  73. 73.
    Rubin PH (1999) Adenomas in ulcerative colitis: endoscopic polypectomy or colectomy? Inflamm Bowel Dis 5(4):304–305PubMedCrossRefGoogle Scholar
  74. 74.
    Odze RD, Farraye FA, Hecht JL et al (2004) Long-term follow-up after polypectomy treatment for adenomalike dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2(7):534–541PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2006

Authors and Affiliations

  • Emil Salmo
    • 1
  • Patrick O’Connolly
    • 2
  • Najib Haboubi
    • 1
  1. 1.Department of Surgical PathologyTrafford Healthcare TrustManchesterUK
  2. 2.Department of Surgical Pathology and Gastrointestinal SurgeryHope HospitalManchesterUK

Personalised recommendations